Novel Therapy for Parkinson's disease

Project: Research

Project Details

Project Description

This project aims were to assess the expression of the SRY gene in post-mortem PD patient brains and to identify potential new drugs to block the SRY gene to halt or slow progression of PD in humans.

Funding awarded to Hudson Institute of Medical Research
Amount awarded - $10,000
Effective start/end date1/01/1831/12/18


  • Parkinson's disease
  • neurodegeneration
  • disease-modifying therapy
  • substantia nigra
  • neuroprotection
  • brain sex differences